First United Bank & Trust trimmed its stake in MetLife, Inc. (NYSE:MET – Free Report) by 12.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,305 shares of the financial services provider’s stock after selling 190 shares during the period. First United Bank & Trust’s holdings in MetLife were worth $107,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. MeadowBrook Investment Advisors LLC lifted its holdings in shares of MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. raised its position in MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC boosted its position in shares of MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares during the period. Peterson Financial Group Inc. bought a new position in shares of MetLife during the third quarter valued at approximately $30,000. Finally, Retirement Wealth Solutions LLC purchased a new stake in shares of MetLife in the fourth quarter worth approximately $32,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.
MetLife Stock Up 1.1 %
Shares of MET stock opened at $86.83 on Tuesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market cap of $60.12 billion, a price-to-earnings ratio of 17.51, a price-to-earnings-growth ratio of 0.64 and a beta of 1.07. The stock’s fifty day moving average price is $83.41 and its 200 day moving average price is $79.54. MetLife, Inc. has a 1-year low of $64.61 and a 1-year high of $89.05.
MetLife Dividend Announcement
Wall Street Analysts Forecast Growth
Several brokerages have commented on MET. JPMorgan Chase & Co. upped their price objective on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Jefferies Financial Group upped their price target on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. Barclays lifted their price objective on shares of MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, January 6th. Piper Sandler raised their target price on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Finally, TD Cowen boosted their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, MetLife has an average rating of “Moderate Buy” and an average target price of $89.92.
Get Our Latest Report on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- How to Use the MarketBeat Dividend Calculator
- A Hidden Winner in Manufacturing and Energy Set for a Breakout
- Insider Buying Explained: What Investors Need to Know
- Beyond Rigetti: Top 3 Quantum Computing Stock Picks
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Dividend Stocks Rewarding Investors With Buybacks
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.